Infliximab for Graft versus Host Disease

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Summary of Abstracts
Project Number:
RB1621-000

Question

  1. What are the benefits and harms of Infliximab for graft-versus-host disease?

Key Message

Three non-randomized studies were found about the benefits and harms of Infliximab for graft-versus-host disease.